News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Trial Launched to Treat Parkinson’s with Reprogrammed Stem Cells
Diana Kwon | Jul 31, 2018
Surgeons will inject approximately 5 million dopamine-producing progenitor cells into patients’ brains.
Stem Cell Vaccine Protects Mice From Cancer
Ruth Williams | Feb 15, 2018
Stem cells and cancer cells have enough molecular similarities that the former can be used to trigger immunity against the latter.
Stem Cells Made by Modifying the Epigenome with CRISPR
Abby Olena | Jan 25, 2018
Researchers use the technique to turn on
in mouse embryonic fibroblasts and convert them into pluripotent cells.
Coriell Institute CEO Dies
Kerry Grens | Jan 4, 2018
Michael Christman oversaw the organization’s well-known biobank and pioneered a personalized medicine initiative.
Researchers Make Knockout Stem Cell Lines in One Step
Ruth Williams | Dec 1, 2017
Combining gene editing and stem-cell induction improves efficiency of functional genetic analyses.
Infographic: Combo Method of Stem Cell Generation
Ruth Williams | Nov 30, 2017
Simultaneous exposure to reprogramming and gene-editing plasmids efficiently produces edited pluripotent colonies.
Partial Reprogramming Offers a Way to Generate High Volumes of Progenitor-Like Cells
Abby Olena | Nov 30, 2017
Activating genes for reprogramming factors for a short time transforms large numbers of differentiated cells into multipotent forms that could be useful for cell-based therapies.
Parkinson’s Disease Cell Therapy Relieves Symptoms in Monkeys
Abby Olena | Aug 30, 2017
Neurons derived from human induced pluripotent stem cells fill in for lost dopamine neurons in a primate model of the disease.
Opinion: Biobanking Has a Consent Dilemma
Timothy Caulfield | Jul 25, 2017
Is the deep uncertainty surrounding fundamental legal and ethical norms putting biobanks in a precarious position?
Women Lose Vision After Stem Cell Treatment
Kerry Grens | Mar 17, 2017
The adipose-derived cells were injected into the patients’ eyes to treat age-related macular degeneration.